JPMIA
J.P. Marvel Investment Advisors Portfolio holdings
AUM
$621M
This Quarter Return
+11.81%
1 Year Return
+21%
3 Year Return
+119.08%
5 Year Return
+235.08%
10 Year Return
–
AUM
$512M
AUM Growth
+$512M
(+54%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
30.82%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
73
New
16
Increased
12
Reduced
18
Closed
3
Top Buys
| 1 |
Apple
AAPL
|
$38.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$30.1M |
| 3 |
Amazon
AMZN
|
$22.4M |
| 4 |
Bank of America
BAC
|
$12.5M |
| 5 |
AbbVie
ABBV
|
$11.6M |
Top Sells
| 1 |
Moderna
MRNA
|
$4.77M |
| 2 |
Newmont
NEM
|
$2.82M |
| 3 |
Franco-Nevada
FNV
|
$1.12M |
| 4 |
Wheaton Precious Metals
WPM
|
$935K |
| 5 |
Thermo Fisher Scientific
TMO
|
$316K |
Sector Composition
| 1 | Healthcare | 31.37% |
| 2 | Technology | 26.7% |
| 3 | Financials | 12.95% |
| 4 | Communication Services | 7.46% |
| 5 | Consumer Discretionary | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $38.3M | 7.49% |
+215,704
| New | +$38.3M |
|
|
2
Alphabet (Google) Class A
GOOGL
$2.57T
| $30.1M | 5.88% |
+10,391
| New | +$30.1M |
|
3
NVIDIA
NVDA
$4.24T
| $26.8M | 5.23% |
91,002
+40
| +0% | +$11.8K |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $25.6M | 5.01% |
38,396
-473
| -1% | -$316K |
|
|
5
Amazon
AMZN
$2.44T
| $22.4M | 4.38% |
+6,721
| New | +$22.4M |
|
6
Morgan Stanley
MS
$240B
| $20.7M | 4.05% |
210,923
-433
| -0.2% | -$42.5K |
|
7
JPMorgan Chase
JPM
$829B
| $17.7M | 3.46% |
111,891
-80
| -0.1% | -$12.7K |
|
8
Eli Lilly
LLY
$657B
| $15.9M | 3.11% |
57,575
+185
| +0.3% | +$51.1K |
|
9
Microsoft
MSFT
$3.77T
| $15.1M | 2.96% |
44,987
+45
| +0.1% | +$15.1K |
|
10
Visa
V
$683B
| $13.9M | 2.71% |
63,927
-115
| -0.2% | -$24.9K |
|
11
Charles River Laboratories
CRL
$8.04B
| $13.5M | 2.64% |
35,818
+440
| +1% | +$166K |
|
12
Pfizer
PFE
$141B
| $13.1M | 2.56% |
221,415
+15,521
| +8% | +$917K |
|
13
CVS Health
CVS
$92.8B
| $12.5M | 2.45% |
121,441
+1,545
| +1% | +$159K |
|
|
14
Bank of America
BAC
$376B
| $12.5M | 2.44% |
+281,047
| New | +$12.5M |
|
15
Lam Research
LRCX
$127B
| $12.2M | 2.38% |
16,964
-78
| -0.5% | -$56.1K |
|
16
Cisco
CSCO
$274B
| $12M | 2.34% |
188,698
| – | – |
|
|
17
Moderna
MRNA
$9.37B
| $11.8M | 2.32% |
46,653
-18,765
| -29% | -$4.77M |
|
18
Johnson & Johnson
JNJ
$427B
| $11.8M | 2.31% |
69,065
-55
| -0.1% | -$9.41K |
|
|
19
AbbVie
ABBV
$372B
| $11.6M | 2.28% |
+86,005
| New | +$11.6M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $11.2M | 2.18% |
+178,978
| New | +$11.2M |
|
21
Akamai
AKAM
$11.3B
| $10.5M | 2.04% |
+89,321
| New | +$10.5M |
|
22
Abbott
ABT
$231B
| $9.98M | 1.95% |
+70,918
| New | +$9.98M |
|
23
Deere & Co
DE
$129B
| $9.79M | 1.91% |
28,547
-35
| -0.1% | -$12K |
|
24
Corning
GLW
$57.4B
| $9.61M | 1.88% |
258,201
| – | – |
|
25
Sherwin-Williams
SHW
$91.2B
| $9.49M | 1.85% |
26,937
-5
| -0% | -$1.76K |
|